Wells Fargo’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Wells Fargo’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-115	Closed	-$1.28K	–	7918
2022 Q4	$1.28K	Buy	115 +3	+3%	+$29	﹤0.01%	6111
2022 Q3	$1K	Buy	112 +26	+30%	+$163	﹤0.01%	6557
2022 Q2	$0	Buy	+86	New	+$489	﹤0.01%	7908
2022 Q1	–	Sell	-3,851	Closed	-$70K	–	8217
2021 Q4	$70K	Buy	+3,851	New	+$48.9K	﹤0.01%	5809
2021 Q3	–	Sell	-127	Closed	-$2K	–	7803
2021 Q2	$2K	Sell	127 -1,757	-93%	-$33.4K	﹤0.01%	6589
2021 Q1	$34K	Sell	1,884 -11,076	-85%	-$232K	﹤0.01%	5996
2020 Q4	$244K	Buy	12,960 +7,505	+138%	+$162K	﹤0.01%	4978
2020 Q3	$115K	Sell	5,455 -1,345	-20%	-$31.4K	﹤0.01%	5204
2020 Q2	$196K	Buy	6,800 +2,895	+74%	+$87.2K	﹤0.01%	4926
2020 Q1	$137K	Buy	3,905 +3,446	+751%	+$111K	﹤0.01%	4903
2019 Q4	$11K	Buy	+459	New	+$8.06K	﹤0.01%	5882

Other funds holding OYST

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wells Fargo's OYST Position: Q1 2023 in Review

Wells Fargo sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 115 shares — an estimated $1.28K sold.

Wells Fargo first reported a position in OYST in Q4 2019 and held it in 11 quarters. The position peaked at $244K in Q4 2020. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

Wells Fargo reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Wells Fargo sold 115 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $1.28K.
Wells Fargo first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 11 quarters.
Wells Fargo's Oyster Point Pharma, Inc. Common Stock position peaked at $244K in Q4 2020.
1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Wells Fargo's 13F filing for Q1 2023, filed 12 May 2023.